Vita Life Sciences Limited (ASX:VLS)

Market Cap	121.28M
Revenue (ttm)	79.51M
Net Income (ttm)	8.78M
Shares Out	55.13M
EPS (ttm)	0.16
PE Ratio	13.93
Forward PE	n/a
Dividend	0.10 (4.69%)
Ex-Dividend Date	Mar 21, 2025

Volume	45,991
Average Volume	10,035
Open	2.130
Previous Close	2.130
Day's Range	2.130 - 2.200
52-Week Range	1.620 - 2.380
Beta	0.53
RSI	76.91
Earnings Date	May 26, 2025

About Vita Life Sciences

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. The company was founded in 1947 and is headquartered in Mascot, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1947
• Employees: 350
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: VLS

Financial Performance

In 2024, Vita Life Sciences's revenue was 79.51 million, an increase of 8.28% compared to the previous year's 73.43 million. Earnings were 8.78 million, a decrease of -3.26%.